The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
As immunotherapy has gained increasing interest as a new foundation for cancer therapy, some atypical response patterns, such as pseudoprogression and hyperprogression, have garnered the attention of physicians. Pseudoprogression is a phenomenon in which an initial increase in tumor size is observed...
Main Authors: | Wenxiao Jia, Qianqian Gao, Anqin Han, Hui Zhu, Jinming Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2019-12-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/1502 |
Similar Items
-
Curative effect assessment of immunotherapy for non‐small cell lung cancer: The “blind area” of Immune Response Evaluation Criteria in Solid Tumors (iRECIST)
by: Peng Song, et al.
Published: (2019-04-01) -
Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression
by: Wenxiao Jia, et al.
Published: (2021-02-01) -
iRECIST: how to do it
by: Thorsten Persigehl, et al.
Published: (2020-01-01) -
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
by: Diogo Garcia, et al.
Published: (2021-06-01) -
Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria
by: Hongge Liang, et al.
Published: (2020-04-01)